id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-293056-kz3w0nfh	Indes, Jeffrey E.	Early Experience with Arterial Thromboembolic Complications in Patents with COVID-19	2020-08-28		.txt	text/plain	1933	125	51	A retrospective case-control study design was used to identify, characterize and evaluate potential risk factors for arterial thromboembolic disease in SARS-CoV-2 positive patients. Although not statistically significant, in patients with arterial thromboembolism, patients who were SARS-CoV-2 positive compared to those testing negative or not tested tended to be male (66.7 % v. Treatment of arterial thromboembolic disease in the COVID-19 positive patients included open thromboembolectomy in 6 patients (40%), anticoagulation alone in 4 (26.7%) and 5 (33.3%) did not require or their overall illness severity precluded additional treatment. The SARS-CoV-2 positive group included patients with a range of COVID-19 16 symptomatology (mild to severe) as well as those tested as part of routine preoperative 17 preparation. Patients with arterial thrombosis who were SARS-CoV-10 2 positive had significantly higher D-dimer levels, BMI, were younger, and less often on 11 antiplatelet medications as compared to patients who were SARS-CoV-2 negative or not tested.	./cache/cord-293056-kz3w0nfh.txt	./txt/cord-293056-kz3w0nfh.txt